Biomaterials Companies and Market Analysis
The biomaterials market contains all sorts of biomaterials such as ceramics, composites, biodegradable, orthopaedic materials, etc. The market is predicted to attain $130.57 billion via 2020, at a development of CGAR of 16% from 2015-2020 prediction. Biomaterials have functions in the discipline of oncology i.e, the learn about of prevention, remedy of cancer. Few biomaterials organizations that are comprised in the international biomaterials market are Zimmer Biomet Holdings, Inc. (U.S.), Carpenter Technology Corporation (U.S.), Covalon Technologies Ltd. (Canada), Evonik Industries AG (Germany), BASF SE (Germany), Invibio Ltd. (U.K.), Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), and Collagen Matrix, Inc. (U.S.)
Related Conference of Biomaterials Companies and Market Analysis
20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
18th International Conference on Human Genomics and Genomic Medicine
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Biomaterials Companies and Market Analysis Conference Speakers
Recommended Sessions
- 3D Printing of Biomaterials
- Advanced Biomaterials
- Bio-based Materials and Sustainability
- Bio-Nanomaterials
- Biodegradable Biomaterials
- Biofunctional Materials
- Bioinspired Materials
- Bioinspired Materials
- Biomaterials
- Biomaterials and Nanotechnology
- Biomaterials and Nanotechnology
- Biomaterials Applications
- Biomaterials Applications
- Biomaterials Companies and Market Analysis
- Biomaterials in Drug Delivery Systems
- Biophotonics and Biomedical Optics
- Dental Biomaterials
- Polymer Biomaterials
- Properties of Biomaterials
- Tissue Engineering and Regenerative Medicine
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)